Cleared Traditional

K872079 - RAICHEM(TM) SPIA(TM) APO A-1 REAGENTS

K872079 is an FDA 510(k) clearance for RAICHEM(TM) SPIA(TM) APO A-1 REAGENTS, manufactured by Reagents Applications, Inc.. The device is a Class 1 Immunology device with product code MSJ cleared through the Traditional 510(k) pathway after a 17-day FDA review.

K872079 · Reagents Applications, Inc. · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1987
Decision
17d
Days
Class 1
Risk

K872079 is an FDA 510(k) clearance for the RAICHEM(TM) SPIA(TM) APO A-1 REAGENTS. Classified as Apolipoproteins (product code MSJ), Class I - General Controls.

Submitted by Reagents Applications, Inc. (San Diego, US). The FDA issued a Cleared decision on June 15, 1987 after a review of 17 days - a notably fast clearance cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 862.1475 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Reagents Applications, Inc. devices

FDA 510(k) Submission Details - K872079

510(k) Number K872079 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 29, 1987
Decision Date June 15, 1987
Days to Decision 17 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
88d faster than avg
Panel avg: 105d · This submission: 17d
Pathway characteristics
Predicate-based equivalence.

MSJ Device Classification - Class 1, General Controls

Product Code MSJ Apolipoproteins
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1475
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - MSJ Apolipoproteins

All 36
Devices cleared under the same product code (MSJ) and FDA review panel - the closest regulatory comparables to K872079.
APOLIPOPROTEIN A1
K873863 · Unipath , Ltd. · Oct 1987
APOLIPOPROTEIN B
K873864 · Unipath , Ltd. · Oct 1987
MEDIX BIOTECH APOLIPOPROTEIN A-I TEST KIT
K872794 · Medix Biotech, Inc. · Sep 1987
SPQ(TM) TEST SYSTEM FOR APOLIPOPROTEIN B
K870564 · Atlantic Antibodies · Mar 1987
SPQ(TM) TEST SYSTEM FOR APOLIPOPROTEIN AL
K870862 · Atlantic Antibodies · Mar 1987
IMMUNOCHEMICAL ASSAY APOLIPOPROTEIN B
K861882 · Orion Corp. · Oct 1986